Back to top

Image: Bigstock

Waters Corporation

Read MoreHide Full Article

Keeping its winning streak alive, Waters Corp. again came up with solid first quarter results on the back of improved operational performance and high demand of its products across geographies. Earnings exceeded the Zacks Consensus Estimate by 18.6% and the year-ago figure by 31.5%. The company has been benefitting from the improving pharmaceutical industry, which is its largest single market and contributes significantly to total revenue. Going forward, the company remains optimistic about its growth going forward, backed by strength in the pharmaceutical markets and recurring revenues. Yet, business in Japan remained sluggish and currency translations affected its overall sales. In addition, increasing R&D expenses, which is expected to rise further, remains an overhang.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Waters Corporation (WAT) - free report >>

Published in